# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-051090
Filing Date
2021-04-16
Accepted
2021-04-16 08:02:32
Documents
4
Period of Report
2021-06-02

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm2112963-1_def14a.htm | DEF 14A | 996483
2 | GRAPHIC | sg_jillmilne-bw.jpg | GRAPHIC | 12713
3 | GRAPHIC | tm212419d1-proxy_1pagebw.jpg | GRAPHIC | 465980
4 | GRAPHIC | tm212419d1-proxy_2pagebw.jpg | GRAPHIC | 418799
| Complete submission text file | 0001104659-21-051090.txt |  | 2231985

Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37467 | Film No.: 21830134
SIC: 2834 Pharmaceutical Preparations